Atlas Trials

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Clinical trial NCT05863052 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05863052
Sponsor
University of Oklahoma
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Immune Checkpoint InhibitorsMetastatic Solid TumorNonsmall Cell Lung CancerMelanomaRenal Cell CarcinomaGastrointestinal CancerSquamous Cell Carcinoma
Start date
2022-01-31
Primary completion
2026-12-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.